Connexin 43 (Cx43) in the heart is normally expressed at the intercalated disk where it commonly forms junctional channels (gap junctions). Many cardiac diseases produce increased or aberrant expression of Cx43, which results in lateralization of the protein in cardiomyocytes. Our group and others have provided evidence that lateralized Cx43 forms unpaired hyperactive hemichannels (non-junctional channels) at the plasma membrane. Excessive opening of these Cx43 hemichannels is associated with cell death during acute ischemia and cardiac muscular dystrophy. Cell death is thought to result from the loss of electrochemical gradients and small cytoplasmic metabolites through the large and modest selective aqueous pore of connexin hemichannels. We and others have indirect evidence indicating that nitric oxide (NO) opens Cx43 hemichannels, promoting cellular dysfunction in the heart and brain. In addition, we have evidence that under conditions that cause lateralization in cardiomyocytes, Cx43 is S-nitrosated. The molecular mechanisms that cause Cx43 hemichannel opening by NO have not been elucidated, despite the importance this may have in cardiac and other pathologies. We propose that a major contributor to the aberrant opening of undocked hemichannels is Cx43 S-nitrosation. In this proposal, we will take advantage of our expertise in connexin hemichannel biophysics to identify the mechanisms by which NO gates Cx43 hemichannels.
Specific Aim 1 will determine whether NO directly opens Cx43 hemichannels via S-nitrosation and identify residues involved.
Specific Aim 2 will identify the precise cytoplasmic domain interactions that mediate the effects of NO on Cx43 gating.
Specific Aim 3 will determine whether S-nitrosated Cx43 hemichannels promote cell and tissue damage. We plan to accomplish these specific aims using an integrative multidisciplinary approach that combines electrophysiology, mutagenesis, fluorescence and NMR spectroscopy, mass spectrometry, and a cardiac disease model. We expect that our work will contribute to the rational development of new pharmacological strategies to target the specific connexin domains involved in aberrant hemichannel gating. This will allow us to achieve specific therapeutic outcomes, for example, to decrease opening of hyperactive hemichannels during myocardial infarction preventing arrhythmias and tissue damage.

Public Health Relevance

Hyperactive connexin hemichannels are found in genetic, cardiac and brain diseases, promoting cell death and tissue damage. We seek to understand the mechanisms that lead to hyperactive hemichannels so that therapeutic approaches to ameliorate the disorders can be designed.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM099490-06
Application #
9402712
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Nie, Zhongzhen
Project Start
2011-07-01
Project End
2021-06-30
Budget Start
2017-09-01
Budget End
2018-06-30
Support Year
6
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Rutgers University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
078795851
City
Newark
State
NJ
Country
United States
Zip Code
07103
García, Isaac E; Villanelo, Felipe; Contreras, Gustavo F et al. (2018) The syndromic deafness mutation G12R impairs fast and slow gating in Cx26 hemichannels. J Gen Physiol 150:697-711
Gonzalez, J Patrick; Ramachandran, Jayalakshmi; Himelman, Eric et al. (2018) Normalization of connexin 43 protein levels prevents cellular and functional signs of dystrophic cardiomyopathy in mice. Neuromuscul Disord 28:361-372
Lopez, William; Ramachandran, Jayalakshmi; Alsamarah, Abdelaziz et al. (2016) Mechanism of gating by calcium in connexin hemichannels. Proc Natl Acad Sci U S A 113:E7986-E7995
Gonzalez, J Patrick; Ramachandran, Jayalakshmi; Xie, Lai-Hua et al. (2015) Selective Connexin43 Inhibition Prevents Isoproterenol-Induced Arrhythmias and Lethality in Muscular Dystrophy Mice. Sci Rep 5:13490
Tong, Xuhui; Lopez, William; Ramachandran, Jayalakshmi et al. (2015) Glutathione release through connexin hemichannels: Implications for chemical modification of pores permeable to large molecules. J Gen Physiol 146:245-54
García, Isaac E; Maripillán, Jaime; Jara, Oscar et al. (2015) Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43. J Invest Dermatol 135:1338-1347
Harris, Andrew L; Contreras, Jorge E (2014) Motifs in the permeation pathway of connexin channels mediate voltage and Ca (2+) sensing. Front Physiol 5:113
Lopez, William; Liu, Yu; Harris, Andrew L et al. (2014) Divalent regulation and intersubunit interactions of human connexin26 (Cx26) hemichannels. Channels (Austin) 8:1-4
Lopez, William; Gonzalez, Jorge; Liu, Yu et al. (2013) Insights on the mechanisms of Ca(2+) regulation of connexin26 hemichannels revealed by human pathogenic mutations (D50N/Y). J Gen Physiol 142:23-35